Buscar
23/08/2024
Experience and satisfaction of participants in colorectal cancer screening programs: a qualitative evidence synthesis
Hortalà, C, Selva, C, Sola, I, Selva, A. Experience and satisfaction of participants in colorectal cancer screening programs: a qualitative evidence synthesis. BMC PUBLIC HEALTH. 2024; 24(1)DOI:10.1186/s12889-024-19678-1. PMID:39180046. IF:3.600(Q1/2D).
23/08/2024
Benefits of Living Over Deceased Donor Kidney Transplantation in Elderly Recipients. A Propensity Score Matched Analysis of a Large European Registry Cohort
Toapanta, N, Comas, J, Revuelta, I, Manonelles, A, Facundo, C, Pérez-Saez, MJ, Vila, A, Arcos, E, Tort, J, Giral, M, Naesens, M, Kuypers, D, Asberg, A, Moreso, F, Bestard, O. Benefits of Living Over Deceased Donor Kidney Transplantation in Elderly Recipients. A Propensity Score Matched Analysis of a Large European Registry Cohort. TRANSPLANT INTERNATIONAL. 2024; 37DOI:10.3389/ti.2024.13452. PMID:39263600. IF:3.000(Q1/1D).
22/08/2024
Comparing temporal changes and predictors of different types of mental health and socio-emotional wellbeing outcomes during COVID-19: an overlapping panel study of Spanish residents
Robles, B, Saez, M, Cabrera-Leon, A, Sánchez-Cantalejo, C, López, MJ, Barceló, MA. Comparing temporal changes and predictors of different types of mental health and socio-emotional wellbeing outcomes during COVID-19: an overlapping panel study of Spanish residents. BMC PUBLIC HEALTH. 2024; 24(1)DOI:10.1186/s12889-024-19817-8. PMID:39174930. IF:3.600(Q1/2D).
20/08/2024
Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study
Tibau, A, Hwang, TJ, Avorn, J, Kesselheim, AS. Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study. BMJ-British Medical Journal. 2024; 386DOI:10.1136/bmj-2023-079126. PMID:39164034. IF:42.700(Q1/1D).
20/08/2024
Bjørn Ibsen: What Made Intensive Care So Critical?
Angeles-Sistac, D, Morán-Chorro, I, Morales-Quinteros, L. Bjørn Ibsen: What Made Intensive Care So Critical?. Cureus. 2024; 16(8)DOI:10.7759/cureus.67281. PMID:39301333. IF:(Q/D).
19/08/2024
Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre
Villamarin, M, Fernández-Hidalgo, N, Viñado, B, González-López, JJ, Rello, P, Escolà-Verg, L. Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024; DOI:10.1093/jac/dkae291. PMID:39158195. IF:3.600(Q2/3D).
19/08/2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients
Halik, A, Tilgner, M, Silva, P, Estrada, N, Altwasser, R, Jahn, E, Heuser, M, Hou, HA, Pratcorona, M, Hills, RK, Metzeler, KH, Fenwarth, L, Dolnik, A, Terre, C, Kopp, K, Blau, O, Szyska, M, Christen, F, Krönke, J, Vasseur, L, Löwenberg, B, Esteve, J, Valk, PJM, Duchmann, M, Chou, WC, Linch, DC, Döhner, H, Gale, RE, Döhner, K, Bullinger, L, Yoshida, K, Damm, F. Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients. Journal of Hematology & Oncology. 2024; 17(1)DOI:10.1186/s13045-024-01590-1. PMID:39160538. IF:40.400(Q1/1D).
19/08/2024
'Gout was like the boss'. A qualitative study exploring the impact of gout on employment
Diaz-Torne, C, Pou, MA, Horne, A, Gasteiger, C, Dalbeth, N. 'Gout was like the boss'. A qualitative study exploring the impact of gout on employment. RMD Open. 2024; 10(3)DOI:10.1136/rmdopen-2024-004443. PMID:39160089. IF:4.700(Q1/1D).
19/08/2024
Usefulness of Xpert MTB/RIF and Xpert Ultra to Categorize Risk of Tuberculosis Transmission to Household Contacts
Mol, A, Sánchez-Montalvá, A, Espinosa-Pereiro, J, Aznar, ML, Salvador, F, Bosch-Nicolau, P, de Souza-Galvao, ML, Jiménez, MA, Rodrigo-Pendás, JA, Millet, JP, Saborit, N, Broto, C, Molina, I, Tórtola, T. Usefulness of Xpert MTB/RIF and Xpert Ultra to Categorize Risk of Tuberculosis Transmission to Household Contacts. Open Forum Infectious Diseases. 2024; 11(8)DOI:10.1093/ofid/ofae450. PMID:39165580. IF:3.800(Q1/3D).
16/08/2024
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study.
Querol L, De Sèze J, Dysgaard T, Levine T, Rao TH, Rivner M, Hartung HP, Kiessling P, Shimizu S, Marmol D, Bozorg A, Colson AO, Massow U, Eftimov F, CIDP01 Study Investigators. Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study.. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024; 95(9)DOI:10.1136/jnnp-2023-333112. PMID:38729747. IF:(Q/D).
16/08/2024
Utility of applying a diagnostic algorithm in giant cell arteritis based on the level of clinical suspicion
Estrada, P, Moya, P, Narváez, J, Moragues, C, Navarro, V, Camacho, O, Roig, D, Cerdà, D, Heredia, S, Reina, D, Corominas, H. Utility of applying a diagnostic algorithm in giant cell arteritis based on the level of clinical suspicion. MEDICINA CLINICA. 2024; 163(3)DOI:10.1016/j.medcli.2023.11.021. PMID:38278759. IF:2.100(Q2/3D).
13/08/2024
Personalized Medicine in Acromegaly: The ACROFAST Study
Marques-Pamies, M, Gil, J, Sampedro-Nuñez, M, Valassi, E, Biagetti, B, Giménez-Palop, O, Hernández, M, Martínez, S, Carrato, C, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón-Muela, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, Rosado, JA, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Personalized Medicine in Acromegaly: The ACROFAST Study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2024; 110(1)DOI:10.1210/clinem/dgae444. PMID:38943661. IF:5.100(Q1/2D).
13/08/2024
PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT
Montoro, J, Ngoya, M, Kulagin, A, Giebel, S, Broers, AEC, Bramanti, S, Halahleh, K, Pérez-Simón, JA, Solano, C, Ozcelik, T, Blaise, D, Sanz, J, Henriques, M, de Latour, RP, Martino, R, Scheid, C, Fox, L, Gromek, T, Jurado, M, Sakellari, I, Van Gorkom, G, Matteucci, P, Nagler, A, Koc, Y, Glass, B. PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT. Blood Advances. 2024; 8(15)DOI:10.1182/bloodadvances.2024013328. PMID:38810260. IF:7.100(Q1/2D).
12/08/2024
Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer
Guigui, A, Basile, G, Zattoni, F, Gallioli, A, Verri, P, Aumatell, J, Gondran-Tellier, B, Lechevallier, E, Bastide, C, Uleri, A, Sica, M, Long-Depaquit, T, Dinoi, G, Moro, FD, Akiki, A, Toledano, H, Rajwa, P, Montorsi, F, Amparore, D, Porpiglia, F, Breda, A, Moschini, M, Baboudjian, M. Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05192-x. PMID:39133324. IF:2.900(Q2/3D).
12/08/2024
Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis The RIBS VI Study
Cuesta, J, Pérez-Vizcayno, MJ, del Blanco, BG, Bosa, F, de Prado, AP, Rumoroso, JR, Romaguera, R, Gutiérrez, H, Touchard, AG, López-Minguez, JR, Trillo, R, Hernandez, JMD, Moreno, R, Velázquez, M, Moris, C, Kockar, MJ, Jiménez-Quevedo, P, Bastante, T, del Val, D, Rivero, F, Alfonso, F. Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis The RIBS VI Study. JACC-Cardiovascular Interventions. 2024; 17(15)DOI:10.1016/j.jcin.2024.05.038. PMID:39142758. IF:11.400(Q1/1D).
12/08/2024
Position Statement on Cardiac Computed Tomography Following Left Atrial Appendage Occlusion
Korsholm, K, Iriart, X, Saw, J, Wang, DD, Berti, S, Galea, R, Freixa, X, Arzamendi, D, De Backer, O, Kramer, A, Cademartiri, F, Cochet, H, Odenstedt, J, Aminian, A, Raeber, L, Cruz-Gonzalez, I, Garot, P, Jensen, JM, Alkhouli, M, Nielsen-Kudsk, JE. Position Statement on Cardiac Computed Tomography Following Left Atrial Appendage Occlusion. JACC-Cardiovascular Interventions. 2024; 17(15)DOI:10.1016/j.jcin.2024.04.050. PMID:39142755. IF:11.400(Q1/1D).
12/08/2024
Early Nonprocedural Bleeding After Left Atrial Appendage Occlusion
Mesnier, J, Cruz-González, I, Guedeney, P, Arzamendi, D, Freixa, X, Nombela-Franco, L, Peral, V, Caneiro-Queija, B, Mangieri, A, Trejo-Velasco, B, Asmarats, L, Cepas-Guillén, P, Salinas, P, Siquier-Padilla, J, Estevez-Loureiro, R, Laricchia, A, O'Hara, G, Montalescot, G, Rodés-Cabau, J. Early Nonprocedural Bleeding After Left Atrial Appendage Occlusion. JACC-Cardiovascular Interventions. 2024; 17(15)DOI:10.1016/j.jcin.2024.05.032. PMID:39023452. IF:11.400(Q1/1D).
12/08/2024
Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants
Furlano, M, Pilco-Teran, M, Pybus, M, Martínez, V, Aza-Carmona, M, Peris, AR, Pérez-Gomez, V, Berná, G, Mazon, J, Hernández, J, de Arizón, LF, Viera, E, Gich, I, Pérez, HV, Gomá-Garcés, E, Dolon, JLA, Ars, E, Torra, R. Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39(9)DOI:10.1093/ndt/gfae031. PMID:38317457. IF:5.600(Q1/1D).
10/08/2024
Impact of Stimulation Frequency on Verbal Fluency Following Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Busteed, L, García-Sánchez, C, Pascual-Sedano, B, Grunden, N, Gironell, A, Kulisevsky, J, Pagonabarraga, J. Impact of Stimulation Frequency on Verbal Fluency Following Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY. 2024; DOI:10.1093/arclin/acae062. PMID:39127889. IF:2.100(Q2/5D).
09/08/2024
Inherited defects of piRNA biogenesis cause transposon de-repression, impaired spermatogenesis, and human male infertility
Stallmeyer, B, Bühlmann, C, Stakaitis, R, Dicke, AK, Ghieh, F, Meier, L, Zoch, A, MacLeod, DM, Steingröver, J, Okutman,Ö, Fietz, D, Pilatz, A, Riera-Escamilla, A, Xavier, MJ, Ruckert, C, Di Persio, S, Neuhaus, N, Gurbuz, AS, Salvarci, A, Le May, N, Mceleny, K, Friedrich, C, van der Heijden, G, Wyrwoll, MJ, Kliesch, S, Veltman, JA, Krausz, C, Viville, S, Conrad, DF, O'Carroll, D, Tüttelmann, F. Inherited defects of piRNA biogenesis cause transposon de-repression, impaired spermatogenesis, and human male infertility. Nature Communications. 2024; 15(1)DOI:10.1038/s41467-024-50930-9. PMID:39122675. IF:15.700(Q1/1D).
08/08/2024
Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis
Silverberg, JI, Bieber, T, Paller, A, Beck, LA, Kamata, M, Puig, L, Wiseman, M, Ezzedine, K, Foley, P, Johansson, E, Dossenbach, M, Akmaz, B, Casillas, M, Karlsson, A, Chovatiya, R. Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis. BRITISH JOURNAL OF DERMATOLOGY. 2024; 191DOI:10.1093/bjd/ljae266.014. PMID:. IF:9.600(Q1/1D).
08/08/2024
Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints
Grunden, N, Calabria, M, García-Sánchez, C, Pons, C, Arroyo, JA, Gómez-Ansón, B, Estévez-Garcia, MD, Belvís, R, Morollón, N, Cordero-Carcedo, M, Mur, I, Pomar, V, Domingo, P. Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints. PLoS One. 2024; 19(8)DOI:10.1371/journal.pone.0302415. PMID:39116061. IF:2.600(Q2/4D).
07/08/2024
Consensus statement addressing controversies and guidelines on pediatric urolithiasis
Güven, S, Tokas, T, Tozsin, A, Haid, B, Lendvay, TS, Silay, S, Mohan, VC, Cansino, JR, Saulat, S, Straub, M, Tur, AB, Akgül, B, Samotyjek, J, Lusuardi, L, Ferretti, S, Cavdar, OF, Ortner, G, Sultan, S, Choong, S, Micali, S, Saltirov, I, Sezer, A, Netsch, C, de Lorenzis, E, Cakir, OO, Zeng, G, Gozen, AS, Bianchi, G, Jurkiewicz, B, Knoll, T, Rassweiler, J, Ahmed, K, Sarica, K. Consensus statement addressing controversies and guidelines on pediatric urolithiasis. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05161-4. PMID:39110242. IF:2.900(Q2/3D).
05/08/2024
Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers
Puig-Davi, A, Martinez-Horta, S, Pérez-Carasol, L, Horta-Barba, A, Ruiz-Barrio, I, Aracil-Bolaños, I, Pérez-González, R, Rivas-Asensio, E, Sampedro, F, Campolongo, A, Pagonabarraga, J, Kulisevsky, J. Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers. ANNALS OF NEUROLOGY. 2024; 96(5)DOI:10.1002/ana.27035. PMID:39099459. IF:7.700(Q1/1D).
03/08/2024
Nutrition users' guides: systematic reviews part 1-structured guide for methodological assessment, interpretation and application of systematic reviews and meta-analyses of non-randomised nutritional epidemiology studies
Zeraatkar, D, de Souza, RJ, Guyatt, GH, Bala, MM, Alonso-Coello, P, Johnston, BC. Nutrition users' guides: systematic reviews part 1-structured guide for methodological assessment, interpretation and application of systematic reviews and meta-analyses of non-randomised nutritional epidemiology studies. Bmj Nutrition, Prevention & Health. 2024; DOI:10.1136/bmjnph-2023-000835. PMID:. IF:(Q/D).
03/08/2024
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, trials
Bissonnette, R, Warren, RB, Pinter, A, Agner, T, Gooderham, M, Schuttelaar, MLA, Crépy, MN, Stingeni, L, Serra-Baldrich, E, Baranowski, K, Korn, S, Kurvits, M, Plohberger, U, Vest, NS, Schliemann, S. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, trials. LANCET. 2024; 404(10451)DOI:10.1016/S0140-6736(24)01027-4. PMID:39033766. IF:88.500(Q1/1D).
03/08/2024
Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice
Verberk, IMW, Jutte, J, Kingma, MY, Vigneswaran, S, Gouda, MMTEE, van Engelen, MP, Alcolea, D, Arranz, J, Fortea, J, Lleó, A, Chevalier, C, Marizzoni, M, van de Giessen, EM, Lemstra, AW, Pijnenburg, YAL, van der Flier, WM, den Braber, A, Wilson, D, Schut, MC, van Harten, AC, Teunissen, CE. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice. ALZHEIMERS & DEMENTIA. 2024; 20(9)DOI:10.1002/alz.14088. PMID:39096164. IF:11.100(Q1/1D).
01/08/2024
SECRETOME FROM EPICARDIAL ADIPOSE TISSUE OF PATIENTS WITH OBESITY INDUCES INFLAMMATION IN HUMAN CARDIOMYOCYTES
Puig, N, Rives, J, Miñambres, I, Casaldaguila, B, Gil, P, Grau-Agramunt, M, Pérez, A, Sanchez-Quesada, JL, Benitez, S. SECRETOME FROM EPICARDIAL ADIPOSE TISSUE OF PATIENTS WITH OBESITY INDUCES INFLAMMATION IN HUMAN CARDIOMYOCYTES. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2024
DELETERIOUS ROLE OF FREE FATTY ACID AND CERAMIDE SPECIES IN THE ALTERATIONS INDUCED BY EPICARDIAL FAT FROM DIABETIC PATIENTS ON CARDIOMYOCYTE FUNCTION
Puig, N, Rives, J, Miñambres, I, Casaldaguila, B, Gil, P, Grau-Agramunt, M, Pérez, A, Sánchez-Quesada, JL, Benitez, S. DELETERIOUS ROLE OF FREE FATTY ACID AND CERAMIDE SPECIES IN THE ALTERATIONS INDUCED BY EPICARDIAL FAT FROM DIABETIC PATIENTS ON CARDIOMYOCYTE FUNCTION. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2024
The impact of diagnosis delay on European patients with generalised myasthenia gravis
Cortes-Vicente, E, Borsi, AJ, Gary, C, Noel, WGJ, Lee, JMS, Karmous, W, Zhang, QY, Gandhi, KH, Batista, AE, Decourcy, JJ, Barlow, SG, Birija, SL, Gibson, GA. The impact of diagnosis delay on European patients with generalised myasthenia gravis. Annals of Clinical and Translational Neurology. 2024; 11(9)DOI:10.1002/acn3.52122. PMID:39090840. IF:3.900(Q1/3D).
01/08/2024
ANTI-HNK-1 IGM AND SNFL LEVELS ARE POTENTIAL BIOMARKERS FOR MONITORING DISEASE ACTIVITY IN ANTI-MAG NEUROPATHY
Pascual-Goñi, E, Martín-Aguilar, L, Lleixà, C, Mariscal, A, Tejada-Illa, C, Caballero-Avila, M, Martinez-Hernandez, E, Serfim, A, Moga, E, Rojas-García, R, López-Pardo, J, Novelli, S, Gallardo, E, Sabater, L, Querol, L. ANTI-HNK-1 IGM AND SNFL LEVELS ARE POTENTIAL BIOMARKERS FOR MONITORING DISEASE ACTIVITY IN ANTI-MAG NEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
ANTI-CASPR1 AUTOIMMUNE NODOPATHY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION
Collet-Vidiella, R, Mederer-Fernandez, T, Caballero-Avila, M, Tejada-Illa, C, Pascual-Goñi, E, Martín-Aguilar, L, Lleixà, C, Querol, L. ANTI-CASPR1 AUTOIMMUNE NODOPATHY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
ANTI-CASPR1 ANTIBODIES ARE ASSOCIATED WITH HLA-DRB1*03:01 ALLELES
Lleixà, C, Martínez-Martínez, L, Pascual-Goñi, E, Martín-Aguilar, L, Caballero-Avila, M, Collet, R, Illa, CT, Gallardo, E, Boera-Carnicero, G, Calahorro, V, Martín, OD, Callegari, I, Cortese, A, Delmont, E, Devaux, J, Giannotta, C, Nobie-Orazio, E, Höftberger, R, Herdewyn, S, Carvajal, A, Torné, L, Jericó-Pascual, I, Querol, L. ANTI-CASPR1 ANTIBODIES ARE ASSOCIATED WITH HLA-DRB1*03:01 ALLELES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
CHARACTERISTICS OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY SUBTYPES: RESULTS FROM A MULTINATIONAL, REAL-WORLD SURVEY
Querol, L, Borsi, A, Gary, C, Noel, W, Karmous, W, DeCourcy, J, Wright, J, Taylor, Y, Iqbal, H, Rinaldi, S. CHARACTERISTICS OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY SUBTYPES: RESULTS FROM A MULTINATIONAL, REAL-WORLD SURVEY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
LONGITUDINAL GAIT ASSESSMENT USING A WEARABLE SYSTEM DETECTS CLINICALLY SIGNIFICANT CHANGES IN PATIENTS WITH PERIPHERAL NEUROPATHIES
Illa, CT, Pegueroles, J, Claramunt-Molet, M, Pi-Cervera, A, Heras-Delgado, A, Gascón-Fontal, J, Idelsohn-Zielonka, S, Vidal, N, Martín-Aguilar, L, Caballero-Avila, M, Lleixà, C, Llansó, L, Rojas-García, R, Querol, L, Pascual-Goñi, E. LONGITUDINAL GAIT ASSESSMENT USING A WEARABLE SYSTEM DETECTS CLINICALLY SIGNIFICANT CHANGES IN PATIENTS WITH PERIPHERAL NEUROPATHIES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
EMPASIPRUBART (ARGX-117) IN MULTIFOCAL MOTOR NEUROPATHY: INITIAL SAFETY AND EFFICACY DATA OF THE PHASE 2 ARDA STUDY
van der Pol, WL, Peric, S, Querol, L, Hussain, Y, Cadour, S, Van de Walle, I, Persson, E, Van Hoomissen, I, Mashchenko, O, Vujcic, M, Van de Steen, O, Allen, JA. EMPASIPRUBART (ARGX-117) IN MULTIFOCAL MOTOR NEUROPATHY: INITIAL SAFETY AND EFFICACY DATA OF THE PHASE 2 ARDA STUDY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
SERUM PROTEOME IN GUILLAIN-BARRE SYNDROME USING AN APTAMER-BASED PROTEOMICS PLATFORM
Martín-Aguilar, L, Collet, R, Lleixà, C, Caballero-Avila, M, Tejada-Illa, C, Pascual-Goñi, E, Sedano-Tous, MJ, Casasnovas, C, Gutiérrez-Gutiérrez, G, Pardo-Fernández, J, Rojas, R, Turón, J, Gallardo, E, Cortés-Vicente, E, Llansó, L, García, JM, Farrés, J, Querol, L. SERUM PROTEOME IN GUILLAIN-BARRE SYNDROME USING AN APTAMER-BASED PROTEOMICS PLATFORM. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
CLINICAL AND IMMUNOLOGICAL RELAPSES ARE INFREQUENT IN PATIENTS WITH ANTI-CNTN1 AUTOIMMUNE NODOPATHY
Caballero-Avila, M, Martín-Aguilar, L, Pascual-Goñi, E, Tejada-Illa, C, Collet, R, Rojas-García, R, Gallardo, E, Martínez-Martínez, L, Doneddu, P, Nobile-Orazio, E, de Winter, J, Alonso-Jimenez, A, del Real, MA, Armangué, T, Delmont, E, Xuclà-Ferrarons, T, Roche, JC, Jauregui, A, González, A, Ortiz, N, Liong, HF, de Rivera, FJR, Sparasci, D, Ripellino, P, Pérez-Pérez, H, Guerrero-Sola, A, Vegezzi, E, Baars, A, Jacobs, B, Wieske, L, Eftimov, F, Lleixà, C, Querol, L. CLINICAL AND IMMUNOLOGICAL RELAPSES ARE INFREQUENT IN PATIENTS WITH ANTI-CNTN1 AUTOIMMUNE NODOPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
PHASE 3 TRIAL DESIGNS EVALUATING RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Lewis, RA, Allen, J, Merkies, ISJ, van Doorn, PA, Sommer, C, Wallstroem, E, Luo, XD, Alonso-Alonso, M, Atassi, N, Querol, L. PHASE 3 TRIAL DESIGNS EVALUATING RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
PHASE 2 EFFICACY AND SAFETY OF RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Querol, L, Lewis, RA, Hartung, HP, Van Doorn, PA, Wallstroem, E, Auwarter, K, Luo, XD, Alonso-Alonso, M, Atassi, N, Hughes, RAC. PHASE 2 EFFICACY AND SAFETY OF RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).